Diagnosis and medical management of abnormal premenopausal and postmenopausal bleeding

References

• Fraser IS, Critchley HO, Broder M, et al. The FIGO recommendations on terminologies and definitions for normal and abnormal uterine bleeding. Semin Reprod Med. 2011;29(05):383–390.
   PubMedGoogle Scholar
• Singh S, Best C, Dunn S, et al. SOGC clinical practice guideline no 292—abnormal uterine bleeding in Pre-Menopausal women. J Obstet Gynaecol Can. 2018;40(5):e391-415–e415.
   Google Scholar
• Heavy Menstrual bleeding assessment and management. NICE guideline NG88. [Published 14 March 2018; cited 2021 May 24]. Available from: www.nice.org.uk/guidance/ng88.
   Google Scholar
• Fraser IS, Critchley HO, Munro MG, et al. Writing group for this menstrual agreement process: a process designed to lead to international agreement on terminologies and definitions used to describe abnormalities of menstrual bleeding. Fertil Steril. 2007;87:466–476.
   PubMed Web of Science ®Google Scholar
• Lim N, Hickey M, Young G, et al. Screening and risk reduction surgery for endometrial or ovarian cancers in lynch syndrome: a systematic review. Int J Gynecol Cancer. 2022;32(5):646–655.
   PubMed Web of Science ®Google Scholar
• Tsakiridis I, Giouleka S, Koutsouki G, et al. Investigation and management of abnormal uterine bleeding in reproductive aged women: a descriptive review of national and international recommendations. Eur J Contracept Reprod Health Care. 2022;27(6):504–517.
   PubMed Web of Science ®Google Scholar
• National Collaborating Centre for Women’s and Children’s Health, National Institute for Health and Clinical Excellence. Clinical guideline CG44: heavy menstrual bleeding. London: Royal College of Obstetricians and Gynaecologists; n.d. http://www.nice.org.uk/nicemedia/live/11002/30401/30401.pdf.
   Google Scholar
• Cartier S, Mayrand MH, Gougeon F, et al. Endometrial biopsy in Low-Risk women: are we over-investigating. J Obstet Gynaecol Can. 2022;44(10):1097–1101.
   PubMed Web of Science ®Google Scholar
• American college of obstetricians and gynecologists committee opinion number 557: management of acute abnormal uterine bleeding in nonpregnant Reproductive-Age women. Obstetrics and Gynecology. 2013;121(4):891–896.
   PubMedGoogle Scholar
• Munro M, Critchley H, Fraser I. The two FIGO systems for normal and abnormal uterine bleeding symptoms and classification of causes of abnormal uterine bleeding in the reproductive years: 2018 revisions. Int J Gynecol Obstet. 2018;143(3):393–408.
   PubMed Web of Science ®Google Scholar
• Dueholm M, Lundorf E, Hansen E, et al. Evaluation of the uterine cavity with magnetic resonance imaging, transvaginal sonography, hysterosonographic examination, and diagnostic hysteroscopy. Fertil Steril. 2001;76(2):350–357.
   PubMed Web of Science ®Google Scholar
• Van Den Bosch T, Ameye L, Van Schoubroeck D, et al. Intra-cavitary uterine pathology in women with abnormal uterine bleeding: a prospective study of 1220 women. Facts Views Vis ObGyn. 2015;7(1):17–24.
   PubMedGoogle Scholar
• Munro MG, Critchley HO, Broder MS, et al. FIGO working Group on menstrual disorders. FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age. Int J Gynecol Obstet. 2011;113:3–13.
   PubMed Web of Science ®Google Scholar
• ACOG Practice bulletin no 128, july 2012. Diagnosis of abnormal uterine bleeding in reproductive-aged women. ACOG. 2012;120(1):197–206.
   Google Scholar
• Lasmar R, Dias R, Barrozo P, et al. Prevalence of hysteroscopic findings and histologic diagnoses in patients with abnormal uterine bleeding. Fertil Steril. 2008;89(6):1803–1807.
   PubMed Web of Science ®Google Scholar
• Goldstein SR, Lumsden MA. MA. Abnormal uterine bleeding in perimenopause. Climacteric. 2017;20(5):414–420.
   PubMed Web of Science ®Google Scholar
• Silverstein MD, Heit JA, Mohr DN, et al. Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med. 1998;158(6):585–593.
   PubMed Web of Science ®Google Scholar
• Pomp ER, Le Cessie S, Rosendaal FR, et al. Risk of venous thrombosis: obesity and its joint effect with oral contraceptive use and prothrombotic mutations. Br J Haematol. 2007;139(2):289–296.
   PubMed Web of Science ®Google Scholar
• Dinger J, Bardenheuer K, Heinemann K. Cardiovascular and general safety of a 24-day regimen of drospirenone-containing combined oral contraceptives: final results from the international active surveillance study of women taking oral contraceptives. Contraception. 2014;89(4):253–263.
   PubMed Web of Science ®Google Scholar
• Douxfils J, Klipping C, Duijkers I, et al. Evaluation of the effect of a new oral contraceptive containing estetrol and drospirenone on hemoastasis parameters. Contraception. 2020;102(6):396–402.
   PubMed Web of Science ®Google Scholar
• Gleeson N, Devitt M, Sheppard BL, et al. Endometrial fibrinolytic enzymes in women with normal menstruation and dysfunctional uterine bleeding. BJOG. 1993;100(8):768–771.
   Google Scholar
• Thorne JG, James PD, Reid RL. Heavy menstrual bleeding: is tranexamic acid a safe adjunct to combined hormonal contraception? Contraception. 2018;98(1):1–3.
   PubMed Web of Science ®Google Scholar
• Bofill Rodriguez M, Lethaby A, Jordan V. Progesterone or progesterone-releasing intrauterine systems for heavy menstrual bleeding. Cochrane Database Syst Rev. 2020;6(6):CD002126.
   PubMedGoogle Scholar
• Marjoribanks J, Lethaby A, Farquhar C. Surgery versus medical therapy for heavy menstrual bleeding. Cochrane Database Syst Rev. 2006;(2):CD003855.
   Google Scholar
• Obstetrics and gynaecology: Twelve things physicians and patients should question. www.ChoosingWiselyCanada.org.
   Google Scholar
• World Health Organization. Research on the menopause in the 1990s. World health organization, technical report series 866. Geneva: WHO, 1996.
   Google Scholar
• Astrup K, Olivarius NdF Frequency of spontaneously occurring postmenopausal bleeding in the general population. Acta Obstet Gynecol Scand. 2004;83(2):203–207.
   PubMed Web of Science ®Google Scholar
• Tempfer CB, Hilal Z, Kern P, et al. Menopausal hormone therapy and risks of endometrial cancer. Cancers. 2020;12(8):2195.
   PubMed Web of Science ®Google Scholar
• Nams PS. The 2022 hormone therapy position statement of the North American menopause society. Menopause. 2022;29(7):766–794.
   Web of Science ®Google Scholar
• Amant F, Moerman P, Neven P, et al. Endometrial cancer. Lancet. 2005;366(9484):491–505.
   PubMed Web of Science ®Google Scholar
• ACOG. Committee opinion summary: the role of transvaginal ultrasonography in evaluating the endometrium of women with postmenopausal bleeding. Obstet Gynecol. 2018;131(5):945–946.
   PubMed Web of Science ®Google Scholar
• Kumar S, Nepal P, Narayanasamy S, et al. Current update on status of saline infusion sonohysterosalpingography. Abdom Radiol. 2022;47(4):1435–1447.
   PubMed Web of Science ®Google Scholar
• Saccardi C, Spagnol G, Bonaldo G, et al. New light on endometrial thickness as a risk factor of cancer: What do clinicians need to know? Cancer Manag Res. 2022;14:1331–1340.
   PubMed Web of Science ®Google Scholar
• Lou Y, Kannappar J, Sathiyathasan S. Unscheduled bleeding on HRT—do we always need to investigate for endometrial pathology? Int J Reprod Contracept Obstet Gynecol. 2017;6(10):4174–4178.
   Google Scholar
• Gredmark T, Kvint S, Havel G, et al. Histopathological findings in women with postmenopausal bleeding. BJOG. 1995;102(2):133–136.
   Google Scholar
• Angioni S, Loddo A, Milano F, et al. Detection of benign intracavitary lesions in postmenopausal women with abnormal uterine bleeding: a prospective comparative study on outpatient hysterscopy and blind biopsy. J Minim Invasive Gynecol. 2008;15(1):87–91.
   PubMed Web of Science ®Google Scholar
• Guido RS, Kanbour-Shakir A, Rulin MC, et al. Pipelle endometrial sampling. Sensitivity in the detection of endometrial cancer. J Reprod Med. 1995;40(8):553–555.
   PubMed Web of Science ®Google Scholar
• Elsandabesee D, Greenwood P. The performance of pipelle endometrial sampling in a dedicated postmenopausal bleeding clinic. J Obstet Gynaecol. 2005;25(1):32–34.
   PubMedGoogle Scholar
• Lee SC, Kaunitz AM, Sanchez-Ramos L, et al. The oncogenic potential of endometrial polyps: a systematic review and meta-analysis. Obstet Gynecol. 2010;116(5):1197–1205.
   PubMed Web of Science ®Google Scholar
• Sasaki LMP, Andrade KRC, Figueiredo A, et al. Factors associated with malignancy in hysteroscopically resected endometrial polyps: a systematic review and meta-analysis. J Minim Invasive Gynecol. 2018;25(5):777–785. 17
   PubMed Web of Science ®Google Scholar
• Vitale S, Haimovich S, Lagana A, et al. Endometrial polyps: an evidence-based diagnosis and management guide. Eur J Obstet Gynecol Reprod Biol. 2021;260:70–77.
   PubMed Web of Science ®Google Scholar
• Ghoubara A, Sundar S, Ewies AAA. Endometrial pathology in recurrent postmenopausal bleeding: observational study of 385 women. Climacteric. 2018;21(4):391–396.
   PubMed Web of Science ®Google Scholar
• Renaud MC, Le T. SOGC-GOC-SCC policy and practice guidelines committee. Epidemiology and investigations for suspected endometrial cancer. J Obstet Gynaecol Can. 2018;40(9):e703–e711.
   PubMed Web of Science ®Google Scholar
• Buchanan C, Robinson M, Macdonald M. Endometrial cancer rate in hormone replacement therapy users with postmenopausal bleeding: retrospective cohort study. Post Reprod Health. 2022;28(3):143–148.
   PubMedGoogle Scholar
• Oderkerk TJ, van de Kar MRD, Cornel KMC, et al. Endometrial cancer after endometrial ablation: a systematic review. Int J Gynecol Cancer. 2022;32(12):1555–1560.
   PubMed Web of Science ®Google Scholar
• Goldstein SR. Appropriate evaluation of postmenopausal bleeding. Menopause. 2018;25(12):1476–1478.
   PubMed Web of Science ®Google Scholar